Market Place
Sourcing Support
Cambrex Opens New Stability Storage Facility In North Carolina
17 Oct 2024 //
PR NEWSWIRE
Snapdragon Develops New Liquid-Phase Peptide Synthesis Technology
19 Sep 2024 //
CONTRACTPHARMA
Cambrex Expands Stability Storage With New Facility In Durham, North Carolina
08 Jul 2024 //
PR NEWSWIRE
Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan
18 Mar 2024 //
PR NEWSWIRE
Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit
02 Nov 2023 //
PRESS RELEASE
Cambrex Announces Sale of Drug Product Business Unit
02 Nov 2023 //
PR NEWSWIRE
Cambrex Completes $38 Million Capacity Expansion in High Point, North Carolina
02 Oct 2023 //
PR NEWSWIRE
Cambrex Celebrates Grand Opening of New Q1 Scientific Facility in Belgium
31 May 2023 //
PRESS RELEASE
Cambrex completes expansion of its Snapdragon API plant
18 May 2023 //
FIERCE PHARMA
Investment firm buys Pfizer facility; Cambrex opens facility in Belgium
06 Apr 2023 //
ENDPTS
Cambrex Recognized with CDMO Leadership Awards for 9th Consecutive Year
01 Mar 2023 //
PR NEWSWIRE
Cambrex Completes Acquisition of Snapdragon Chemistry
18 Jan 2023 //
PR NEWSWIRE
Cambrex acquires ingredient manufacturer Snapdragon Chemistry
21 Nov 2022 //
ENDPTS
Cambrex to Acquire Snapdragon Chemistry
21 Nov 2022 //
PRNEWSWIRE
Cambrex to Invest $16.5M in New R&D Facility in Minneapolis, Minnesota
27 Oct 2022 //
PRNEWSWIRE
Cambrex Expands Stability Storage in Ireland and Belgium
07 Oct 2022 //
CONTRACTPHARMA
Cambrex, MilliporeSigma open European facilities in ongoing expansion efforts
06 Oct 2022 //
ENPTS
Cambrex Announces Stability Storage Expansions in Ireland and Belgium
04 Oct 2022 //
PRNEWSWIRE
Cambrex Completes First Phase of $30 Million Capacity Expansion Project
01 Sep 2022 //
PRNEWSWIRE
Cambrex Acquires Leading EU Stability Storage Company Q1 Scientific
01 Jun 2022 //
PRNEWSWIRE
Cambrex Completes Large-Scale U.S. API Expansion
19 Apr 2022 //
CONTRACTPHARMA
Expanding API manufacturing operations: Cambrex and Asymchem
14 Apr 2022 //
EUROPEANPHARMACEUTICALREVIEW
Cambrex Completes Large-Scale US API Expansion
12 Apr 2022 //
PRNEWSWIRE
Avondale Pharmaceuticals Announces Development Partnership with Cambrex
25 Mar 2022 //
PRWEB
Cambrex Expands Biopharmaceutical Testing Services Biz
01 Mar 2022 //
CONTRACTPHARMA
BioCina completes takeover of Pfizer-owned Australia plant; and more
07 Oct 2021 //
ENDPTS
Cambrex to Invest $30M to Expand Manufacturing Center of Excellence
07 Oct 2021 //
PRNEWSWIRE
Cambrex Adds Kilogram-Scale Mfg. Capabilities at Estonia
25 May 2021 //
CONTRACTPHARMA
Cambrex Expands API Mfg. Capacity in Charles City
17 Nov 2020 //
CONTRACTPHARMA
Cambrex Completes Edinburgh Expansion
12 Oct 2020 //
CONTRACTPHARMA
Cambrex Completes Expansion of Edinburgh Solid Form Screening Facility
12 Oct 2020 //
PHARMTECH
Cambrex Expands Flexible Manufacturing Capacity in Sweden
01 Jul 2020 //
PRESS RELEASE
Cambrex Names Thomas Loewald as CEO
01 Jul 2020 //
PHARMTECH
Cambrex Names Thomas Loewald as CEO
18 Jun 2020 //
CONTRACT PHARMA
CDMO Cambrex completes biopharmaceutical expansion at Durham, NC facility
09 Apr 2020 //
CPHI-ONLINE
Cambrex Completes Biopharmaceutical Expansion at its Durham, NC Facility
07 Apr 2020 //
GLOBENEWSWIRE
Cambrex Announces Completion of Acquisition by the Permira Funds
04 Dec 2019 //
GLOBE NEWSWIRE
CDMO Cambrex sells for $2B after aggressive acquisitions
08 Aug 2019 //
FIERCE PHARMA
Cambrex Expands Process Development at Edinburgh Facility
30 Jul 2019 //
CONTRACT PHARMA
Cambrex Completes New Process and Analytical Development Facility
04 Jun 2019 //
CONTRACT PHARMA
Cambrex opening new high-potency API facility in U.S.
12 Apr 2019 //
FIERCE PHARMA
FDA gets specific on data integrity rules; Lupin, Dishman tagged with 483s
14 Dec 2018 //
FIERCE PHARMA
Cambrex acquires Avista for $252m, becomes integrated CDMO
22 Nov 2018 //
IN-PHARMATECHNOLOGIST
Cambrex upgrades generic API manufacturing facilities in Milan
09 Oct 2018 //
MANUFACTURING CHEMIST
Cambrex closes on $425M deal for dosage-form CDMO Halo Pharma
20 Sep 2018 //
FIERCE PHARMA
The rise and fall of the U.S. pharmaceutical chemical maker
17 Sep 2018 //
CEN
API manufacturer Cambrex buys Halo Pharma for $425M
25 Jul 2018 //
ENDPTS
Cambrex expands in Italy and Sweden: New hires, labs to be ready in 2019
13 Jun 2018 //
IN PHARMATECHNOLOGIST
Cambrex Expands Generic API Research and Devp Capabilities at Milan, Italy Site
12 Jun 2018 //
GLOBENEWSWIRE
Cambrex Completes Pilot Plant Expansion at its High Point, NC Facility
15 May 2018 //
GLOBNEWSWIRE
Cambrex hiring 12 new analytical scientists post $3.2m expansion
26 Apr 2018 //
IN PHARMATECHNOLOGIST
Cambrex Completes New $3.2 Million Analytical Research & Development Laboratory
24 Apr 2018 //
GLOBENEWSWIRE
Cambrex caps latest manufacturing addition at North Carolina plant
18 Apr 2018 //
FIERCE PHARMA
Cambrex invests in new continuous flow technology at its High Point (NC, USA)
17 Apr 2018 //
MANUFACTURING
Cambrex up on innovator API demand, aims for double-digit growth
12 Feb 2018 //
IN PHARMATECHNOLOGIST
Cambrex adds continuous manufacturing to sites in U.S. and Europe
18 Jan 2018 //
FIERCE PHARMA
Cambrex & Astrazeneca Hold Ceremony To Mark Long-term Supply Agreement At Karlskoga, Sweden Facility
16 Jan 2018 //
PRESS RELEASE
Cambrex’s small scale API expansion open in Iowa, US
09 Nov 2017 //
IN PHARMATECHNOLOGIST
Cambrex adds potent API capacity citing growing generic opportunities
17 Oct 2017 //
IN PHARMATECHNOLOGIST
